Wojciech Baran

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

Kim Papp, Kristian Reich, C. Paul et al. · British Journal of Dermatology · 2016 · 449 citations

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 125 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus

Anja Hänsel, Claudia Günther, Wojciech Baran et al. · Journal of Autoimmunity · 2012 · 69 citations

Inflammation, Molecular Immunology, Autoimmune Disease +12

Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study

Laura K. Ferris, Elyssa Ott, Jingzhi Jiang et al. · Journal of Dermatological Treatment · 2019 · 53 citations · Full text

IL-6 and IL-10 Promoter Gene Polymorphisms in Psoriasis Vulgaris

Wojciech Baran, Grzegorz Mazur, Emine Baran · Acta Dermato Venereologica · 2008 · 44 citations · Full text

Immunogenetics, Autoimmune Disease, Medicine +14